Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies

TT Lai, B Gericke, M Feja, M Conoscenti… - npj Parkinson's …, 2023 - nature.com
Synucleinopathies are neurodegenerative disorders characterized by alpha-synuclein
(αSyn) accumulation in neurons or glial cells, including Parkinson's disease (PD), dementia …

Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics

D Yadav, P Kumar - Neurochemistry international, 2022 - Elsevier
Neurotransmitters are considered as a fundamental regulator in the process of neuronal
growth, differentiation and survival. Parkinson's Disease (PD) occurs due to extensive …

Neuropsychiatric disorders in Parkinson's disease: what do we know about the role of dopaminergic and non-dopaminergic systems?

K Dujardin, V Sgambato - Frontiers in neuroscience, 2020 - frontiersin.org
Besides the hallmark motor symptoms (rest tremor, hypokinesia, rigidity, and postural
instability), patients with Parkinson's disease (PD) have non-motor symptoms, namely …

Searching for new anxiolytic agents among derivatives of 11-dialkylaminoethyl-2, 3, 4, 5-tetrahydrodiazepino [1, 2-a] benzimidazole

DV Maltsev, AA Spasov, DS Yakovlev… - European Journal of …, 2021 - Elsevier
A study on the anxiolytic activity of the new derivatives of 11-dialkylaminoethyl-2, 3, 4, 5-
tetrahydrodiazepino [1, 2-a] benzimidazole, containing privileged scaffolds of …

Dose and time-dependence of acute intermittent theta-burst stimulation on hippocampus-dependent memory in parkinsonian rats

Y Wang, J Liu, Y Hui, Z Wu, L Wang, X Wu… - Frontiers in …, 2023 - frontiersin.org
Background The treatment options for cognitive impairments in Parkinson's disease (PD) are
limited. Repetitive transcranial magnetic stimulation has been applied in various …

Glycolysis inhibition partially resets epilepsy-induced alterations in the dorsal hippocampus-basolateral amygdala circuit involved in anxiety-like behavior

VA Khatibi, M Salimi, M Rahdar, M Rezaei, M Nazari… - Scientific Reports, 2023 - nature.com
Pharmacoresistant temporal lobe epilepsy affects millions of people around the world with
uncontrolled seizures and comorbidities, like anxiety, being the most problematic aspects …

Activation of AMPA receptors in the lateral habenula produces anxiolytic effects in a rat model of Parkinson's disease

J Zhang, X Wang, RE Bernardi, J Ju, S Wei… - Frontiers in …, 2022 - frontiersin.org
Background: Parkinson's disease (PD) is commonly accompanied with anxiety disorder,
however, the mechanisms underlying PD-mediated anxiety remain elusive. The lateral …

The effect of URB597, exercise or their combination on the performance of 6-OHDA mouse model of Parkinson disease in the elevated plus maze, tail suspension test …

M Ebrahimi-Ghiri, F Shahini, MR Zarrindast - Metabolic Brain Disease, 2021 - Springer
Parkinson disease (PD) is a progressive neurodegenerative disorder that is often
accompanied by motor and psychiatric symptoms. Various approaches have been proposed …

Investigating affective neuropsychiatric symptoms in rodent models of Parkinson's disease

L Boi, G Fisone - International Review of Neurobiology, 2024 - Elsevier
Affective neuropsychiatric disorders such as depression, anxiety and apathy are among the
most frequent non-motor symptoms observed in people with Parkinson's disease (PD) …

[HTML][HTML] Imaging of cerebral tryptophan metabolism using 7-[18F] FTrp-PET in a unilateral Parkinsonian rat model

H Endepols, BD Zlatopolskiy, J Zischler, N Alavinejad… - NeuroImage, 2022 - Elsevier
Degradation products of the essential amino acid tryptophan (Trp) are important signaling
molecules in the mammalian brain. Trp is metabolized either through the kynurenine …